Oral opioid prescribing to active duty US military personnel: a cross-sectional population.

Autor:	Junge JM; Department of Anesthesiology and Pain Medicine, Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.; Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Naval Biotechnology Group, Naval Medical Center Portsmouth, Portsmouth, VA, USA., Murray H; Family Medicine, US Naval Hospital Jacksonville, Jacksonville, Florida, USA., Goldman AH; Bone & Joint Sports Medicine Institute, Department of Orthopaedic Surgery, Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Booth GJ; Department of Anesthesiology and Pain Medicine, Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.; Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Naval Biotechnology Group, Naval Medical Center Portsmouth, Portsmouth, VA, USA., Balazs GC; Bone & Joint Sports Medicine Institute, Department of Orthopaedic Surgery, Naval Medical Center Portsmouth, Portsmouth, Virginia, USA gcbalazs@gmail.com.; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Jazyk:	angličtina
Zdroj:	Regional anesthesia and pain medicine [Reg Anesth Pain Med] 2024 May 07; Vol. 49 (5), pp. 339-345. Date of Electronic Publication: 2024 May 07.
DOI:	10.1136/rapm-2023-104495
Abstrakt:	Introduction: While civilian opioid prescriptions have seen a dramatic decline in recent years, there are few studies investigating trends in opioid prescription in the active duty military population. We evaluated oral opioid prescribing patterns to active duty military personnel in the Military Health System (MHS) from 2017 to 2020 to determine the incidence of opioid prescriptions as well as demographic and military-specific risk factors for receiving an oral opioid prescription. Methods: The MHS Data Repository was queried from 2017 to 2020 to identify all outpatient oral opioid prescriptions to active duty military personnel in August of each year as well as demographic information on the study population. Data were evaluated in a logistic regression model, and ORs of receiving an oral opioid prescription were calculated for each factor. Results: The proportion of active duty military personnel receiving an oral opioid prescription declined from 2.71% to 1.26% (53% relative reduction) over the study period. Within the logistic regression model, female military personnel were significantly more likely to receive opioid prescriptions compared with men, and there was a stepwise increase in likelihood of an opioid prescription with increasing age. Army and Marine personnel, personnel without a history of military deployment and those stationed within the continental USA were significantly more likely to receive an opioid prescription. Discussion: The substantial decrease in oral opioid prescriptions to active duty military personnel mirrors data published in the civilian community. The identified risk factors for receiving an opioid prescription may be potential targets for future interventions to further decrease prescribing. Competing Interests: Competing interests: None declared. ("I am a military service member. This work was prepared as part of my official duties. Title 17 U.S.C. 105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17 U.S.C. 101 defines a United States Government work as a work prepared by a military service member or employee of the United States Government as part of that person’s official duties.")
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu